INIS
fibrosis
100%
patients
54%
levels
36%
chlorides
36%
sweat
36%
pancreas
27%
genotype
27%
hospitals
18%
children
18%
guidelines
18%
evaluation
9%
laboratories
9%
monitoring
9%
screening
9%
phenotype
9%
information
9%
usa
9%
values
9%
algorithms
9%
classification
9%
symptoms
9%
newborns
9%
infants
9%
wisconsin
9%
refining
9%
pseudomonas
9%
Medicine and Dentistry
Patient
90%
Cystic Fibrosis Transmembrane Conductance Regulator
63%
Cystic Fibrosis
36%
Chloride
36%
Sweat
36%
Diseases
27%
Diagnosis
27%
Genotype
27%
Metabolic Syndrome
18%
Family
18%
Consensus
18%
Phenotype
9%
Patient Monitoring
9%
Infection
9%
Newborn Screening
9%
Evaluation Study
9%
Nutritional Status
9%
Age
9%
Immunoreactive Trypsinogen
9%
Pancreas Function
9%
Recursive Partitioning
9%
Analysis
9%
Therapeutic Procedure
9%
Nursing and Health Professions
Cystic Fibrosis Transmembrane Conductance Regulator
63%
Cystic Fibrosis
36%
Diseases
27%
Diagnosis
27%
Practice Guideline
18%
Pediatric Hospital
18%
Physician
18%
Metabolic Syndrome X
18%
Consensus
18%
Infant
18%
Culture
18%
Infection
9%
Newborn Screening
9%
Evaluation Study
9%
Nutritional Status
9%
Recursive Partitioning
9%
Classification Algorithm
9%
Symptom
9%
Laboratory
9%
Analysis
9%
Biochemistry, Genetics and Molecular Biology
Cystic Fibrosis Transmembrane Conductance Regulator
63%
Cystic Fibrosis
36%
Chloride
36%
Genotyping
27%
Consensus
18%
Phenotype
9%
Pseudomonas aeruginosa
9%
Age
9%
Newborn Screening
9%
Recursive Partitioning
9%
Immunoreactive Trypsinogen
9%
Classification Algorithm
9%
Pancreas Function
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis Transmembrane Conductance Regulator
63%
Chloride
36%
Cystic Fibrosis
36%
Diseases
27%
Metabolic Syndrome X
18%
Infection
9%
Pseudomonas aeruginosa
9%
Symptom
9%
Immunology and Microbiology
Sweat
36%
Genotype
27%
Consensus
18%
Phenotype
9%
Classification Algorithm
9%
Newborn Screening
9%
Pancreas Function
9%
Age
9%
Microbiology
9%